Pay in 4 interest-free payments of $6.24 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Large-scale clinical trials, such as the SUSTAIN-6 trial, found that semaglutide significantly reduced the risk of major adverse cardiovascular events (MACE), including heart attacks and strokes, in people with type 2 diabetes and high cardiovascular risk
However, more pronounced and sustained weight loss results are generally observed after approximately 12 weeks of continuous treatment, with peak outcomes often achieved between 6 to 12 months
When combined with personalized nutrition guidance and activity coaching, it promotes steady, systemic fat reductionno surgery necessary
Caffeine intake more than 200 mg per day is not recommended during pregnancy or breastfeeding
268 participants who were switched to placebo at 20 weeks
US$ 23.52
US$ 21.68
US$ 21.60
US$ 24.81
US$ 21.76
US$ 21.99
